Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ABTABT
Showing 7 of 30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ABBOTT LABORATORIES

CITADEL ADVISORS LLC holds 8.6M shares of ABT (ABBOTT LABORATORIES), worth $780.1M as of 2026-Q2. The position was increased (+348.7% shares). ABT represents 0.1% of CITADEL ADVISORS LLC's portfolio.

Current Value

$780.1M

Current Shares

8.6M

Total Value Change

+$738.9M

Total Shares Change

+8.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.6M
+348.7%
$780.1M0.1%$90.10
51
2026-Q1
Decreased
1.9M
-7.9%
$196.7M0.0%$101.31
0
2025-Q4
Increased
2.1M
+255.1%
$260.6M0.0%$123.00
50
2025-Q3
New
585,801
-
$78.5M0.0%$130.91
41
2025-Q1
Exited
0
-100.0%
$00.0%$128.48
0
2024-Q4
Increased
903,000
+149.6%
$102.1M0.0%$108.98
48
2024-Q3
Decreased
361,753
-63.2%
$41.2M0.0%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used